Phenotypic Characteristics of Inflammatory Bowel Disease in Southeast Asian Population - A Multi-centered US Study
2 other identifiers
observational
N/A
1 country
1
Brief Summary
This is a retrospective, case control study of inflammatory bowel disease. This study will analyze the phenotypic characteristics of inflammatory bowel disease in the Southeast Asian population and will help describe clinical characteristics and serologic profiles in Southeast Asians with inflammatory bowel disease, comparing the phenotype differences to historical Caucasian controls. The data from this study will help identify the phenotype characteristics of different ethnic groups and study the epidemiological patterns of the disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jul 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2007
CompletedFirst Submitted
Initial submission to the registry
December 12, 2007
CompletedFirst Posted
Study publicly available on registry
December 14, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2008
CompletedJanuary 28, 2015
January 1, 2015
1.3 years
December 12, 2007
January 26, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Phenotypic characteristics of inflammatory bowel disease in southeast asian population
Retrospective chart review
12 months
Eligibility Criteria
Patients will be selected from the IBD registry maintained at respective institutions. Subjects from the Indian sub-continent will be identified using their country of birth, parents' ethnicity, number of years since leaving the country of birth, and number of years residing in the United States.
You may qualify if:
- Patients with origins from the Indian sub-continent
- Patients will be selected from the IBD registry maintained at respective institutions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, Irvinelead
- University of Kentuckycollaborator
- University of Texas Southwestern Medical Centercollaborator
- Texas Health Resourcescollaborator
- Mayo Cliniccollaborator
- Jefferson Medical College of Thomas Jefferson Universitycollaborator
Study Sites (1)
University of California, Irvine Medical Center
Orange, California, 92868, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nimisha K Parekh, M.D.
University of California, Irvine
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Clinical Professor
Study Record Dates
First Submitted
December 12, 2007
First Posted
December 14, 2007
Study Start
July 1, 2007
Primary Completion
October 1, 2008
Study Completion
October 1, 2008
Last Updated
January 28, 2015
Record last verified: 2015-01